LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Type May Affect Heart Disease Risk

By LabMedica International staff writers
Posted on 28 Aug 2012
The blood type of an individual may affect their risk of coronary heart disease (CHD) as people with certain blood types are more likely to develop the disease than are others.

Studies have indicated that ABO blood group might influence plasma lipid level and recently, several genome-wide association studies found that variants at ABO locus were associated with plasma lipid levels and inflammatory markers that were associated with the CHD risk.
Scientists at the Harvard School of Public Health (Boston, MA, USA) examined data covering nearly 90,000 participants aged from 30 to 75 who were followed for 20 years or more in two large well-known American studies that included a cohort of 62,073 women and a cohort of 27,428 adults.

The proportions of men and women in the studies with various blood types were the same as in the general population, and the scientists were able to control for a number of factors that can affect health and heart disease risk, such as age, gender, race, body mass index, diet, smoking, menopause, and medical history.

The blood type AB is the rarest blood type, it occurs in around 7% of Americans, while type O, the most common, occurs in around 43%. Those with blood type AB had a 23% increased risk for heart disease, those with type B had an 11% increased risk, and those with type A had a 5% increased risk, compared to people with type O.

The mechanisms that cause blood type to affect heart disease risk were not investigated, but evidence from other studies gives some clues. Blood type A is linked to higher levels of low-density lipoprotein (LDL) cholesterol, the "bad" cholesterol that clogs up arteries. Blood type AB is linked to inflammation, which can affect how blood vessels work, and people with blood type O have higher levels of a compound that has a beneficial effect on blood flow and clotting.

Lu Qi, MD, PhD, the senior author of the study, said, "It is important to know your blood type, just as it is good to know your cholesterol and blood pressure levels. If you know you are at higher risk, you can reduce the risk by adopting a healthier lifestyle, such as eating right, exercising, and not smoking." Armed with findings like these, health care providers can tailor treatments more effectively. For instance, patients with blood type A could be advised to reduce cholesterol in their diet to lower their risk of heart disease. The study was published on August 14, 2012, in the journal Arteriosclerosis, Thrombosis and Vascular Biology.

Related Links:
Harvard School of Public Health


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Silver Member
PCR Plates
Diamond Shell PCR Plates

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more